Monoclonal antibody administration. Current clinical pharmacokinetic status and future trends
- PMID: 1511531
- DOI: 10.2165/00003088-199223020-00001
Monoclonal antibody administration. Current clinical pharmacokinetic status and future trends
Erratum in
- Clin Pharmacokinet 1992 Oct;23(4):310. Begent J [corrected to Begent RH]
Similar articles
-
Immunotoxin therapy of malignancy.Important Adv Oncol. 1992:111-35. Important Adv Oncol. 1992. PMID: 1582669 Review. No abstract available.
-
Serotherapy of cancer.Semin Oncol. 1989 Jun;16(3):180-98. Semin Oncol. 1989. PMID: 2658082 Review. No abstract available.
-
[Prospects for improving antibody therapy for carcinoma].Zhonghua Yi Xue Za Zhi. 2004 Jul 17;84(14):1145-6. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15387972 Chinese. No abstract available.
-
[Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].Nihon Rinsho. 1989 Jun;47(6):1391-5. Nihon Rinsho. 1989. PMID: 2475654 Japanese. No abstract available.
-
Immunoconjugates in drug delivery systems.Targeted Diagn Ther. 1990;3:121-39. Targeted Diagn Ther. 1990. PMID: 2131008 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources